News: Research

New findings could improve treatment options for people with hard-to-treat infections.

NIH-funded UT team and colleagues from Metagenomi Thereapeutics discovered highly efficient enzyme could enable targeted gene editing within the human body.

The discovery could also lend itself to the development of future antibacterial therapies.

The finding suggests other chemo drugs, too, may be making cancer cells cause a surprising immune-system reaction.

An innovative imaging technique enabled dramatically higher resolution structures than previous efforts.

A new antibody design blocks cytomegalovirus from hiding from the immune system and could lead to safer, more effective treatments for vulnerable patients.

The breakthrough could be used in a new vaccine or antibody therapy to fight mpox, the disease caused by the monkeypox virus.

Advanced biotechnology repurposes two bacterial immune systems to correct large stretches of DNA.

Bryan Davies, a professor in the Department of Molecular Biosciences, and a team have identified antibodies that offer a direct hit on dangerous bacteria.

UT Austin and Sanofi partner to build tool that predicts translation efficiency of mRNA sequences.